AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Business Editors/Health/Medical Writers
SAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--Nov. 24, 2003
FzioMed, Inc. will present clinical data of its Oxiplex(R)/AP Gel, Adhesion Barrier for Abdominal/Pelvic Surgery, at the Annual Congress of the European Society of Gynaecological Endoscopy being held November 26-29, 2003, in Luxembourg. Richard Berg, Ph.D., Vice President of Research and Development, will present results indicating that Oxiplex/AP Gel is well tolerated in patients and reduces the formation of adhesions following gynecologic surgery.
The majority of patients undergoing gynecologic surgery will develop post-operative adhesions: abnormal …
Source: HighBeam Research, FzioMed's Adhesion Barrier, Oxiplex/AP Gel, Reduces Extent and...